Cite
HARVARD Citation
Sarsenbayeva, G. et al. (2018). Immunogenicity and safety of a novel seasonal influenza preservative-free vaccine manufactured in Kazakhstan: Results of a randomized, comparative, phase II clinical trial in adults. Human vaccines & immunotherapeutics. 14 (3), pp. 609-614. [Online].